ALLO – allogene therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Allogene Therapeutics (ALLO) Up 6.4% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Allogene Therapeutics: Cema-Cel Promising Among Innovative CAR T-Cell Therapies [Seeking Alpha]
Allogene Therapeutics, Inc. (NASDAQ: ALLO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Allogene Therapeutics, Inc. (ALLO) Q2 2024 Earnings Call Transcript [Seeking Alpha]
Allogene Therapeutics, Inc. (NASDAQ: ALLO) had its price target raised by analysts at Citigroup Inc. from $7.00 to $8.00. They now have a "buy" rating on the stock.
Form 4 Allogene Therapeutics, For: Aug 21 Filed by: Douglas Earl Martin
Form 144 Allogene Therapeutics, Filed by: Douglas Earl Martin
Form 10-Q Allogene Therapeutics, For: Jun 30
Form 8-K Allogene Therapeutics, For: Aug 07
Form 4 Allogene Therapeutics, For: Jun 18 Filed by: MESSEMER DEBORAH M.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.